医学
非甾体
疾病
痴呆
阿尔茨海默病
神经保护
对症治疗
重症监护医学
发病机制
内科学
作者
John C.S. Breitner,Peter P. Zandi
标识
DOI:10.1056/nejm200111223452110
摘要
In this issue of the Journal, in 't Veld and colleagues1 report the results of a long-term prospective study of the relation between the use of nonsteroidal antiinflammatory drugs (NSAIDs) and the onset of Alzheimer's disease. This important article appears to resolve puzzling conflicts among the results of prior studies of the possible neuroprotective effects of NSAIDs.The dementia of Alzheimer's disease has an insidious onset and a gradually progressive course. Although the pathogenesis of the disease remains controversial, the process is widely thought to begin in midlife or earlier, decades before the appearance of symptoms. At that point, largely . . .
科研通智能强力驱动
Strongly Powered by AbleSci AI